
Anthropic pre-IPO futures have fallen as much as 9% since their Coinbase debut, with contracts on both Coinbase and Binance hitting fresh lows despite fresh attention from traders. According to crypto.news, the ANTHROPIC/USDC contract on Coinbase opened around $1,728 and was trading near $1,648 at the time of writing, representing a decline of roughly 7%. During the same period, the contract swung between a June 22 high of $1,769 and a June 23 low of $1,560, highlighting elevated volatility immediately after launch. Binance's ANTHROPIC/USDT perpetual contract dropped about 5% between June 22 and June 23 to roughly $1,630, with the contract touching an all-time low of $1,545 on June 23.
The weakness comes despite Anthropic announcing a partnership with Micron Technology, a company valued at roughly $1.37 trillion, suggesting that traders have remained focused on pricing risks surrounding the eventual IPO rather than recent business developments. Recent trading activity has drawn comparisons with the path taken by SpaceX-related contracts before the aerospace company's public debut. According to crypto.news, some investors appear to be reassessing the risks attached to pre-IPO perpetual products after SpaceX contracts traded well above the eventual IPO price. SpaceX pre-IPO perpetuals changed hands around $155 before the company's Nasdaq debut, about 15% higher than its $135 IPO price, leaving some traders exposed to losses once public trading began. Subsequent developments have added to those concerns, with SpaceX shares falling more than 10% after analysts at KeyBanc initiated coverage with a 'Sector Weight' rating.
Another factor keeping traders cautious is the lack of information surrounding Anthropic's eventual IPO terms, as Anthropic has not yet disclosed the number of shares it plans to sell through its IPO filing. As a result, the eventual IPO price could settle either above or below current futures levels once additional details become available. Coinbase has already highlighted this risk to market participants, with the exchange warning that the final IPO price could end up 25% higher or 25% lower than where the perpetual contracts trade before listing. The regulatory wrapper provides legitimacy within a supervised framework, though the rules for marking, auditing, and policing these contracts are still being developed in real time.
On June 16, Coinbase unveiled its Everything Exchange, introducing pre-IPO perpetual futures linked to private companies including SpaceX, OpenAI, and Anthropic. According to reports from Coinbase, this represents a significant expansion of access for ordinary investors who previously required accredited investor status to participate in private share sales. The contracts are structured as cash-settled derivatives on a regulated futures exchange, allowing traders to open positions without owning actual private securities. Coinbase Global (COIN) climbed 2% on Monday as the exchange rolled out these new offerings, signaling strong market interest in private-company speculation. The ANTHROPIC-PERP and OPENAI-PERP pre-IPO markets opened on or after 11:00 AM UTC on June 22, with Coinbase Markets enabling full trading capabilities including limit, market, stop, and stop-limit orders on both instruments.
Coinbase's expansion into pre-IPO perpetual futures represents a strategic pivot from pure-play crypto platform to global 'Everything Exchange'. As reported by market analysts, this diversification into synthetic derivatives mitigates the company's reliance on highly volatile localized crypto cycles while establishing a unique, high-margin revenue vertical that bypasses legacy spot volume dependencies. The perpetual contracts don't require complex underlying equity dilution tracking, making them an efficient, highly scalable mechanism to drive international transaction fees and boost platform monetization. By offering 24/7 speculative access to the world's most hyped AI startups, Coinbase reinforces its competitive moat against legacy brokerages and financial institutions. Despite recent challenges, Wall Street maintains a 'Moderate Buy' consensus rating with a mean price target of nearly $231, indicating potential upside of about 40% from current levels.